AdoRx Therapeutics Announces Initial Funding of $10 Million for the Discovery of New Cancer Therapeutics

EDINBURGH, Scotland, June 21, 2018 -- (Healthcare Sales & Marketing Network) -- AdoRx Therapeutics, a UK based drug discovery company focused on the identification of new cancer therapeutics, today announced that it has closed an initial $10 million inves... Biopharmaceuticals, Oncology, Venture Capital AdoRx Therapeutics, adenosine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news